Applera Earmarks $75M for Discovery, Diagnostics | GenomeWeb

Relying on the branding power of its subsidiaries, Applera announced a $75 million corporation-wide push to increase its business. The company says Applied Biosystems, Celera Diagnostics, and Celera Genomics will pony up equal finances to reach the target over the next 12 to 15 months. The goal of the initiative is primarily to commercialize therapeutic and diagnostic products based on Celera’s genomic and SNP data and on disease-related data to be generated this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.